Investors buy Warner Chilcott in $3 billion acquisition deal

Share this article:
An investor group led by JPMorgan Chase and Credit Suisse
First Boston has acquired drug maker Warner Chilcott in a $3 billion
deal.
The drug company maintains joint headquarters in Northern Ireland
and Rockaway, N.J., with most of its 1,000 employees in the U.S.
Warner Chilcott is the maker of several products in the oral contraceptives, hormone replacement therapy, urology and dermatology markets.
Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.